feed,title,long_url,short_url
Benzinga,FDA Approves Novartis' Lutathera As First Therapy For Pediatric Patients With Gastroenteropancreatic Neuroendocrine Tumors,https://benzinga.com/general/biotech/24/04/38388424/fda-approves-novartis-lutathera-as-first-therapy-for-pediatric-patients-with-gastroenteropancreat,https://da.gd/VK9U3
Benzinga,"Incyte Should Consider Significant Stock Buyback And Prioritize R&D, Analyst Recommends",https://benzinga.com/analyst-ratings/analyst-color/24/04/38388366/incyte-should-consider-significant-stock-buyback-and-prioritize-r-d-analyst-recomme,https://da.gd/elIBs
Benzinga,Cryptocurrency XT.com's Price Increased More Than 3% Within 24 hours,https://benzinga.com/insights/cryptocurrency/24/04/38388375/cryptocurrency-xt-coms-price-increased-more-than-3-within-24-hours,https://da.gd/6OPO
